TimothyDriscollMD

Assistant Professor, Pediatrics, Duke University School of Medicine

Dr. Driscoll is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
2100 Erwin Rd
Durham, NC 27705
Phone+1 919-620-4467

Fax+1 919-668-1180

Duke University HospitalFellowship, Pediatric Hematology/Oncology, 1993 - 1997
Nationwide Children's Hospital/Ohio State UniversityResidency, Pediatrics, 1990 - 1993
Ohio State University College of MedicineClass of 1990

PubMed

65 citations
Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia
Michael A. Pulsipher, Xia Han, Shannon L. Maude, Theodore W. Laetsch, Muna Qayed
Blood Cancer Discovery. 2021-12-01
37 citations
Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemia.
John E. Levine, Stephan A. Grupp, Michael A. Pulsipher, Andrew C. Dietz, Susana Rives
Journal for Immunotherapy of Cancer. 2021-08-01
Non-inferiority of fragmented care for high-risk pediatric neuroblastoma patients: a single institution analysis.
Aaron Tarnasky, Meredith A. Achey, Luke P. Wachsmuth, Hannah Williamson, Samantha M. Thomas
Pediatric Hematology and Oncology. 2021-05-10

Lectures

Molecular Detection of Minimal Residual Disease Precedes Morphological Relapse and Could be Used to Identify Relapse in Pediatric and Young Adult B-Cell Acute Lymphobl...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Ticked off: Researchers Target Lyme Disease Vaccine with Aid of $1.9 Million Federal GrantSeptember 9th, 2020